Oct 16, 2019 Atomoxetine, sold under the brand name Strattera, is a medication used to treat attention deficit hyperactivity disorder (ADHD) [12] and, to a lesser extent, cognitive
Descriptions Atomoxetine is used to treat attention-deficit hyperactivity disorder (ADHD) in children, teenagers, and adults
It works by increasing the levels of norepinephrine, a natural substance in the brain that
The purpose of this article was to systematically review the literature on stimulant and atomoxetine combination therapy, in particular: 1) Characteristics of patients with
Atomoxetine (Brand Name: Strattera) is an effective and safe alternative to the stimulant medications most commonly used to treat attention deficit hyperactivity disorder (ADHD)
Atomoxetine is a selective norepinephrine reuptake inhibitor [ 2 ]
Stimulant medications for attention disorders, weight loss, or to stay awake; Ziprasidone; This list may not describe all possible interactions
Atomoxetine (Strattera) was the first FDA-approved nonstimulant medication for ADHD
The children’s symptoms significantly improved; their ADHD rating scale scores dropped from a 34 to a 21
Atomoxetine is susceptible to drug-drug interactions with other substrates that use CYP 2D6 as well as inducers and inhibitors of
It is the only nonstimulant medication approved by the FDA for treatment of adult ADHD
Atomoxetine and stimulants have both been demonstrated effective as single agents for treatment of attention deficit hyperactivity disorder in children, adolescents, and adults
Strattera is a commonly prescribed medication for children, teens, and adults
Atomoxetine warnings
Second-line option for those who do not tolerate stimulants or have concerns about abuse
general feeling of discomfort or illness
Atomoxetine was the first non-stimulant approved for treatment of ADHD in the United States by the Food and Drug Administration (FDA)
67, P =
hypertensive crisis), CNS overstimulation, hyperpyrexia, monoclonus, rigidity, autonomic instability, death (additive effects) procarbazine
Considering dopamine is one of the most important stimulant neurotransmitters in the brain, this would clarify a lot
Intuniv (guanfacine ER) and Kapvay (clonidine ER) are approved for kids ages 6 to 17 and can be used alone or in combination with stimulant
Strattera: Non-Stimulant Medication for ADHD